Upregulation of αGM-CSF-receptor in nonatopic asthma but not in atopic asthma

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 5, 1997, Pages 666-672

  Kotsimbos, A Thomas C ^a   Humbert, Marc ^b   Minshall, Eleanor ^a   Durham, Stephen ^b   Pfister, Rudi ^c   Menz, Gunter ^c   Tavernier, Jan ^d   Kay, A Barry ^b   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Hochgebirgsklinik   (Switzerland)

^d Roche   (Belgium)

Author keywords

GM CSF receptor; Intrinsic asthma; macrophages

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE ACTIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0030983513     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70029-0     Document Type: Article

References (52)

1. McFadden ER Jr, Gilbert IA. Asthma. N Engl J Med 1992;327:1928-37.
2. Sterk PJ, Bell EH. Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 1989;2:267-74.
3. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969;24:176-9.
4. Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, et al. Identification of T lymphocytes, macrophages and activated eosinophils in the bronchial mucosa in intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992;146:500-6.
5. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Assoufi B, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-13.
6. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88: 935-42.
7. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani A-MA, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-74.
8. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
9. Carroll MP, Durham SR, Walsh G, Kay AB. Activation of neutrophils and monocytes after allergen- and histamine-induced broncho-constriction. J Allergy Clin Immunol 1985;75:290-6.
10. Cluzel M, Damon M, Chanez P, Bousquet J, Crastes de Paulet A, Michel FB, et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 1987;80:195-201.
11. Joseph M, Tonnel AB, Torpier G, Capron A, Arnoux B, Benveniste J. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest 1983; 71:221-30.
12. Holgate ST, Abraham WM, Barnes PJ, Lee TH. Pharmacology and treatment. In: Holgate ST, Hopewell JB L, Burney PGJ, Drazen JM, Hargreave FE, Kay AB, et al., editors. The role of inflammatory process in airway hyperresponsiveness. Oxford: Blackwell Scientific Publications, 1989:179-221.
13. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
14. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage inflammatory protein-1a activates basophils and mast cells. J Exp Med 1992;176:781-6.
15. Rankin JA. The contribution of alveolar macrophages to hyperreactive airway disease. J Allergy Clin Immunol 1989;83:722-9.
16. Poulter LW, Janossy G, Power C, Sreenan S, Burke C. Immunological/physiological relationships in asthma: potential regulation by lung and macrophages. Immunol Today 1994;15:258-61.
17. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-26.
18. Metcalf D. The granulocyte-macrophage colony stimulating factor. Science 1985;229:16-22.
19. Metcalf D. The molecular biology and functions of the granulocytemacrophage colony-stimulating factors. Blood 1986;67:257-67.
20. Corrigan CJ, Hamid Q, North J, Barkans J, Moqbel R, Durham S, et al. Peripheral blood CD4 but not CDS T-lymphocyte in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th-2 type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995;12:567-78.
21. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
22. Robinson DS, Ying S, Bentley AM, Meng Q, North J, Durham SR. et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92:397-403.
23. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
24. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
25. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994;150:1038-48.
26. Bentley AM, Durham SR, Kay AB. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Invest Allergol Clin Immunol 1994;4:222-32.
27. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harian JM, Klebanoff SJ, et al. Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature human eosinophil and neutrophil function, surface receptor expression and survival. J Clin Invest 1986;78:1220-8.
28. Miyajima A, Mui AL-F, Ogorochi T, Sakamaki K. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993;82:1960-74.
29. Wognum AW, Westerman Y, Visser TP, Wagemaker G. Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets. Blood 1994;84:764-74.
30. Lopez AF, Vadas MA, Woodcock JM, Milton SE, Lewis A, Elliott MJ, et al. Interleukin-5, interleukin-3, and granulocyte-macrophage colony stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J Biol Chem 1991;266:24741-7.
31. Ronco LV, Doyle SE, Raines M, Park LS, Gasson JC. Conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor-binding subunit essential for tyrosine phosphorylation and proliferation. J Immunol 1995;154:3444-53.
32. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990;87:6934-8.
33. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, et al. A human high affinity interleukin-5 receptor (IL-5) is composed of an IL-5-specific a chain and a β chain shared with the receptor for GM-CSF. Cell 1991;66:1175-84.
34. Kitamura T, Sato N, Arai K, Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared β-subunit for human IL-3 and GM-CSF receptors. Cell 1991;66:1165-74.
35. Lanfrancone L, Pelicci G, Brizzi MF, Arouica MG, Casciari C, Giuli S, et al, Overexpression of Sch proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to be beta receptor subunit. Oncogene 1995;10:907-17.
36. Kay AB. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1b and tumour necrosis factor-a. Immunology 1992;77:330-7.
37. Vancheri C, Ohtoshi T, Cox G, Xaubet A, Abrams JS, Gauldie J, et al. Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol 1991;4:11-7.
38. Nakagawa Y, Kosugi H, Miyajima A, Arai K, Yokota T. Structure of the gene encoding the alpha subunit of the human granulocytemacrophage colony-stimulating factor receptor. J Biol Chem 1994; 269:10905-12.
39. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
40. Hamid Q, Wharton J, Terenghi G, Hassall C, Aimi J, Taylor K, et al. Localization of atrial natiuretic peptide mRNA and immunoreactivity in rat heart and human atrial appendage. Proc Natl Acad Sci USA 1987;84:6760-4.
41. Hamid Q. Isotopic localization of cellular mRNA in clinical material using RNA probes. In: Herrington CS and McGee J.O'D., editors. Diagnostic molecular pathology: a practical approach. Vol I. Oxford: IRL Press, 1992:169-85.
42. Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
43. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993:147:697-704.
44. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
45. Metzger WJ, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M, et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: a description of model and local airway inflammation. Am Rev Respir Dis 1987;135:433-40.
46. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 1995;95:211-8.
47. Kinoshita T, Yokota, Arai K, Miyajima A. Suppression of apoptotic death in hematopoietic cells by signalling through the Il-3/GM-CSF receptors. EMBO J 1995;14:266-75.
48. Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, et al. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 1991;174:749-52.
49. Ying S, Robinson DS, Varney V, Meng Q, Tsicopoulos A, Moqbel R, et al. TNF mRNA expression in allergic inflammation. Clin Exp Allergy 1991;21:745-50.
50. Busse WW. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J Allergy Clin Immunol 1990;85:671-83.
51. Spiteri MA, Poulter LW. Characterization of immune inducer and suppressor macrophages from normal human lung. Clin Exp Immunol 1991;83:157-62.
52. Hamid Q, Barkans J, Robinson DS, Durham R, Kay AB. Coexpression of CD25 and CD3 in atopic allergy and asthma. Immunology 1992;75:659-63.